Back to Patient Education
In 2026, an international consensus of endocrinologists, gynecologists, fertility specialists and — importantly — patients agreed to retire the name *Polycystic Ovary Syndrome (PCOS)* and replace it with Polyendocrine Metabolic Ovarian Syndrome (PMOS).
The condition has not changed. The science behind it has not changed. What has changed is the name, and that change is bigger than it looks.
Poly = many
Metabolic = involving how the body handles sugar, insulin and fat
Ovarian = involving the ovaries
Syndrome = a cluster of features, not a single disease
The "endocrine" piece (the *E* hidden inside the new name through the word *Polyendocrine* in the original proposal — *Polyendocrine Metabolic Ovarian Syndrome*) signals that this is a *whole-body hormonal condition*, not a problem confined to the ovaries.
Most women with the syndrome had been told three confusing things by the old name:
1. "You have cysts on your ovaries."
*Reality:* What ultrasound shows are not true cysts. They are small immature follicles that didn't ovulate. The name suggested a surgical problem; it isn't one.
2. "This is an ovary disease."
*Reality:* The ovaries are downstream. The upstream issues are insulin resistance, abnormal androgen production, disordered hormone signalling and — increasingly recognised — long-term cardiovascular and metabolic risk.
3. "This is a fertility problem."
*Reality:* Fertility is one part of it. Many women with the syndrome face acne, hair changes, mood symptoms, sleep apnoea, fatty liver, and a 4–7× higher lifetime risk of type-2 diabetes. The old name made the rest invisible.
So the rename to PMOS does three things at once:
Centres the *metabolic and hormonal* nature of the condition.
Removes the misleading "polycystic" label.
Validates the experience of women without any visible "cysts" who were told for years they didn't qualify.
Largely, no. Diagnosis still uses the same Rotterdam criteria — irregular ovulation, signs of high androgens, and polycystic-appearing ovaries on ultrasound (any two of three). Other conditions still need to be ruled out (thyroid, prolactin, late-onset CAH, Cushing's). What is likely to expand is the *workup*:
A standard metabolic panel now sits alongside the hormone panel: HbA1c, fasting insulin, lipid profile, blood pressure, waist circumference.
Mental health screening (anxiety, depression, body image) is increasingly part of routine PMOS care.
Long-term risk counselling — diabetes, cardiovascular disease, endometrial cancer — is brought forward to the first consultation, not deferred.
The principles are the same. The emphasis has shifted. Earlier, the conversation often started with "let's regulate your periods" — and stopped there. Now it starts with: *"how do we treat the syndrome behind your periods, and protect you for the next 30 years?"*
In practice that means:
Lifestyle (food, movement, sleep, stress) remains the most powerful single intervention.
Inositol (Myo + D-chiro, 40:1) and metformin are mainstream for the insulin resistance side.
Combined OC pills still work very well for cycle regulation, acne and androgen suppression — when there is no contraindication.
Mirena IUS is a useful option when contraception, heavy bleeding or endometrial protection are also goals.
Ovulation induction (letrozole, clomiphene) is the first-line fertility treatment when pregnancy is planned.
Bariatric / metabolic referral is offered more freely when BMI is high and lifestyle alone has plateaued.
Cardiometabolic surveillance — BP, HbA1c, lipids — is repeated yearly, not just once at diagnosis.
So if you have an existing PCOS treatment plan that is working, nothing needs to be stopped or restarted because of the name change. Continue your plan and ask your gynecologist to flag any updates at the next review.
This is the most important question, and the honest answer is: *the rename itself does not cure anyone, but it changes how the system treats you, and that does affect outcomes.*
Expected downstream effects include:
Earlier diagnosis for women previously dismissed as "borderline" because their ovaries didn't look polycystic on ultrasound.
More complete care because doctors and patients now expect metabolic and mental-health attention as standard, not optional.
Less stigma because the new name doesn't sound like a disease of "broken ovaries".
Better fertility planning because the wider metabolic picture is optimised earlier.
In other words, the rename is a *systems-level* intervention. The biggest beneficiaries are the women in the next decade who will be diagnosed faster, treated more completely, and screened more proactively.
1. Don't panic and don't switch doctors over a name.
Your treatment hasn't suddenly become wrong. The PCOS plan you are on is still valid. The labels will catch up over the next few years.
2. Update your vocabulary.
"I have PMOS, previously called PCOS." This single sentence opens a more accurate conversation with any new clinician, employer or insurance representative.
3. Ask for a complete metabolic check, at least once a year.
HbA1c, fasting glucose and insulin, lipid profile, blood pressure, weight + waist measurement, vitamin D, TSH. This is the part that was most under-emphasised in the old name.
4. Take the mental health side seriously.
Anxiety and depression are 2–3× higher with PMOS. If you're struggling, mention it. There is treatment, and treating the mood often improves cycles, sleep and metabolic numbers too.
5. Be a voice for the change.
When friends or family say "polycystic ovaries", explain gently that it isn't really about cysts. Sharing accurate information is how a new name actually becomes a new understanding.
PMOS is the same syndrome, but in a more honest dress. The science is unchanged; the framing is upgraded; the long-term care is broader. If you have PCOS today, you have PMOS today. The good news is that the system is finally describing it the way it has always behaved — and that is the first step toward better outcomes for every woman living with it.
*References: international 2026 consensus on PMOS terminology; Endocrine Society and ASRM 2024–2026 communications; published in peer-reviewed gynecology and endocrinology journals.*
Hormonal Health 11 min read
PCOS Is Now PMOS — What The New Name Means For You
By Dr. Neha Singhania • 2026-02-26
A name 90 years in the making — and now finally updated
In 2026, an international consensus of endocrinologists, gynecologists, fertility specialists and — importantly — patients agreed to retire the name *Polycystic Ovary Syndrome (PCOS)* and replace it with Polyendocrine Metabolic Ovarian Syndrome (PMOS).
The condition has not changed. The science behind it has not changed. What has changed is the name, and that change is bigger than it looks.
So what does PMOS stand for?
Poly = many
Metabolic = involving how the body handles sugar, insulin and fat
Ovarian = involving the ovaries
Syndrome = a cluster of features, not a single disease
The "endocrine" piece (the *E* hidden inside the new name through the word *Polyendocrine* in the original proposal — *Polyendocrine Metabolic Ovarian Syndrome*) signals that this is a *whole-body hormonal condition*, not a problem confined to the ovaries.
Why the old name was misleading
Most women with the syndrome had been told three confusing things by the old name:
1. "You have cysts on your ovaries."
*Reality:* What ultrasound shows are not true cysts. They are small immature follicles that didn't ovulate. The name suggested a surgical problem; it isn't one.
2. "This is an ovary disease."
*Reality:* The ovaries are downstream. The upstream issues are insulin resistance, abnormal androgen production, disordered hormone signalling and — increasingly recognised — long-term cardiovascular and metabolic risk.
3. "This is a fertility problem."
*Reality:* Fertility is one part of it. Many women with the syndrome face acne, hair changes, mood symptoms, sleep apnoea, fatty liver, and a 4–7× higher lifetime risk of type-2 diabetes. The old name made the rest invisible.
So the rename to PMOS does three things at once:
Will it change your diagnosis?
Largely, no. Diagnosis still uses the same Rotterdam criteria — irregular ovulation, signs of high androgens, and polycystic-appearing ovaries on ultrasound (any two of three). Other conditions still need to be ruled out (thyroid, prolactin, late-onset CAH, Cushing's). What is likely to expand is the *workup*:
Will it change your treatment?
The principles are the same. The emphasis has shifted. Earlier, the conversation often started with "let's regulate your periods" — and stopped there. Now it starts with: *"how do we treat the syndrome behind your periods, and protect you for the next 30 years?"*
In practice that means:
So if you have an existing PCOS treatment plan that is working, nothing needs to be stopped or restarted because of the name change. Continue your plan and ask your gynecologist to flag any updates at the next review.
Will it affect your *outcome*?
This is the most important question, and the honest answer is: *the rename itself does not cure anyone, but it changes how the system treats you, and that does affect outcomes.*
Expected downstream effects include:
In other words, the rename is a *systems-level* intervention. The biggest beneficiaries are the women in the next decade who will be diagnosed faster, treated more completely, and screened more proactively.
What you should do as a patient — a 5-point action plan
1. Don't panic and don't switch doctors over a name.
Your treatment hasn't suddenly become wrong. The PCOS plan you are on is still valid. The labels will catch up over the next few years.
2. Update your vocabulary.
"I have PMOS, previously called PCOS." This single sentence opens a more accurate conversation with any new clinician, employer or insurance representative.
3. Ask for a complete metabolic check, at least once a year.
HbA1c, fasting glucose and insulin, lipid profile, blood pressure, weight + waist measurement, vitamin D, TSH. This is the part that was most under-emphasised in the old name.
4. Take the mental health side seriously.
Anxiety and depression are 2–3× higher with PMOS. If you're struggling, mention it. There is treatment, and treating the mood often improves cycles, sleep and metabolic numbers too.
5. Be a voice for the change.
When friends or family say "polycystic ovaries", explain gently that it isn't really about cysts. Sharing accurate information is how a new name actually becomes a new understanding.
Bottom line
PMOS is the same syndrome, but in a more honest dress. The science is unchanged; the framing is upgraded; the long-term care is broader. If you have PCOS today, you have PMOS today. The good news is that the system is finally describing it the way it has always behaved — and that is the first step toward better outcomes for every woman living with it.
*References: international 2026 consensus on PMOS terminology; Endocrine Society and ASRM 2024–2026 communications; published in peer-reviewed gynecology and endocrinology journals.*